Log In
Print
BCIQ
Print
Print this Print this
 

morphine/naltrexone (Embeda) (ALO-01)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionMorphine sulfate extended-release with sequestered naltrexone
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor agonist/antagonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat chronic moderate to severe malignant and non-malignant pain; Treat chronic moderate to severe non-malignant pain; Treat chronic moderate to severe pain; Treat chronic pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today